Hyperbaric Fellowships

match-fellowships-new.jpg

Fellowship Match 

EMRA is launching Fellowship Match!  We are adding fellowships daily.  

Look for fellowships using criteria important to you.

    • Geographic location
    • Fellowship type or training opportunity 
    • Advanced Degrees Offered?
    • Is Moonlighting Allowed?
    • Length of Program?
    • Number of Shifts per month?
    • Save your favorites
    • Export your fellowships to a spreadsheet to look at offline
EMRA---Fellowship-Guide-2018---CC.jpg

EMRA Fellowship Guide

Chapter 29 Undersea and Hyperbaric Medicine Fellowship

Undersea and hyperbaric medicine (UHM) is a unique subspecialty of emergency medicine that involves the therapeutic use of oxygen under pressure to treat disease. Hyperbaric oxygen is used to treat dive emergencies, arterial gas embolisms, radiation injuries, complex wounds, carbon monoxide (CO) poisoning, deadly infections, ocular emergencies, and much more. The specialty of UHM includes treatment with hyperbaric oxygen but also the study of extreme pressure environments, immersion effects, and marine life injuries.

The patient population is diverse, including recreational and commercial divers, patients requiring daily wound care, and critically ill patients. Fellowship training prepares physicians to care for patients with emergent and elective indications, participate in research, and become leaders in the field.

Go to Chapter 29

Related Content

Mar 17, 2021

Policy Compendium Sunset Review 2021

2022 EMRA Representative Council Sunset Review

Mar 23, 2025

Severe Finger Entrapment in Gas Filler Cap Valve of 2003 Ford Expedition

How do you manage a case of a patient's finger stuck so completely in a Ford Explorer gas valve that EMS arrives with part of the vehicle attached to your patient? Hint: Consider the use of a nasopharyngeal tube, an angle grinder, and DoorDash.

Nov 02, 2022

Critical Care Alert: A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest

Every minute counts for long-term outcomes in out-of-hospital cardiac arrest. Does the route of administration for lifesaving medications play a role? This EMRA Critical Care Alert dives into the PARAMEDIC-3 trial, comparing outcomes in OHCA patients who were treated with intraosseous access versus intravenous access.